Single Versus Combined Antibiotic Therapy for Bacterial Peritonitis in CAPD Patients
Information source: Chulalongkorn University
ClinicalTrials.gov processed this data on August 23, 2015 Link to the current ClinicalTrials.gov record.
Condition(s) targeted: Peritonitis
Intervention: ceftazidime+ciprofloxacin (Drug); ceftazidime monotherapy (Drug); cefazolin+gentamicin (Drug); cefazolin monotherapy (Drug)
Phase: N/A
Status: Recruiting
Sponsored by: Chulalongkorn University Official(s) and/or principal investigator(s): Nalinee Saiprasertkit, MD., Principal Investigator, Affiliation: Chulalongkorn University
Overall contact: Talerngsak Kanjanabuch, Assoc. Prof., Phone: 662-2564321, Ext: 211, Email: golfnephro@hotmail.com
Summary
To compare the efficacy of single versus combined antibiotic therapy for bacterial
peritonitis in CAPD patients.
Clinical Details
Official title: Single Versus Combined Antibiotic Therapy for Bacterial Peritonitis in Continuous Ambulatory Peritoneal Dialysis Patients
Study design: Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Subject), Primary Purpose: Treatment
Primary outcome: relapse or recurrent rate
Detailed description:
To compare relapse and recurrent rate of peritonitis between single and combined antibiotic
regimens for bacterial peritonitis in CAPD patients.
Eligibility
Minimum age: 15 Years.
Maximum age: 75 Years.
Gender(s): Both.
Criteria:
Inclusion Criteria:
- age >/= 18 years old
- ESRD patients on continuous ambulatory peritoneal dialysis more than 4 weeks
- presence of symptom or sign of peritonitis
- presence of WBC >100cell/mm3 with PMN >50% in peritoneal dialysate or gram stain
positive for gram positive or gram negative bacteria
Exclusion Criteria:
- presence of polymicrobial organism, non-fermentative gram negative organism, fungus,
mycobacteria in peritoneal fluid or culture-negative
- peritonitis from the organisms that required combined antibiotic therapy according to
ISPD guideline 2010
- hospital-acquired peritonitis
- presence of catheter-related infection
- history of peritonitis within 4 weeks
- currently taking antibiotic
- allergic to the antibiotic that used in the study(penicillin or cephalosporin or
quinolone or aminoglycoside)
Locations and Contacts
Talerngsak Kanjanabuch, Assoc. Prof., Phone: 662-2564321, Ext: 211, Email: golfnephro@hotmail.com
Chulalongkorn university, Bangkok 10330, Thailand; Recruiting Nalinee Saiprasertkit, MD., Phone: 66865899700, Email: nsaiprasertkit@gmail.com Nalinee Saiprasertkit, MD., Principal Investigator Worapot Treamtrakanpon, MD., Sub-Investigator
Additional Information
Starting date: December 2012
Last updated: February 6, 2013
|